Literature DB >> 7934528

Hepatitis C viraemia in recipients of Irish intravenous anti-D immunoglobulin.

J P Power, E Lawlor, F Davidson, P L Yap, E Kenny-Walsh, M J Whelton, T J Walsh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7934528     DOI： 10.1016/s0140-6736(94)90679-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

1.  Detection of genome-scale ordered RNA structure (GORS) in genomes of positive-stranded RNA viruses: Implications for virus evolution and host persistence.

Authors:  Peter Simmonds; Andrew Tuplin; David J Evans
Journal:  RNA       Date:  2004-07-23       Impact factor: 4.942

2.  Long-term evolution of the hypervariable region of hepatitis C virus in a common-source-infected cohort.

Authors:  J McAllister; C Casino; F Davidson; J Power; E Lawlor; P L Yap; P Simmonds; D B Smith
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

3.  The issue of anti-D: an integrated seamless approach from recognition of need to bedside administration.

Authors:  M J Ryan; S Joyce; N O'Brien; E Lynch; G Burke; M R Cahill
Journal:  Ir J Med Sci       Date:  2005 Jul-Sep       Impact factor: 1.568

4.  Risk factors for the transmission of hepatitis C virus infection in the Turkish population.

Authors:  Cetin Karaca; Yilmaz Cakaloğlu; Kadir Demir; Sadakat Ozdil; Sabahattin Kaymakoğlu; Selim Badur; Atilla Okten
Journal:  Dig Dis Sci       Date:  2006-02       Impact factor: 3.199

Review 5.  Role of regulatory T cells during virus infection.

Authors:  Tamara Veiga-Parga; Sharvan Sehrawat; Barry T Rouse
Journal:  Immunol Rev       Date:  2013-09       Impact factor: 12.988

6.  A new fetal RHD genotyping test: costs and benefits of mass testing to target antenatal anti-D prophylaxis in England and Wales.

Authors:  Ala Szczepura; Leeza Osipenko; Karoline Freeman
Journal:  BMC Pregnancy Childbirth       Date:  2011-01-18       Impact factor: 3.007

Review 7.  Manufacture of immunoglobulin products for patients with primary antibody deficiencies - the effect of processing conditions on product safety and efficacy.

Authors:  Albert Farrugia; Isabella Quinti
Journal:  Front Immunol       Date:  2014-12-23       Impact factor: 7.561

Review 8.  Uncovering Resistance to Hepatitis C Virus Infection: Scientific Contributions and Unanswered Questions in the Irish Anti-D Cohort.

Authors:  Jamie A Sugrue; Cliona O'Farrelly
Journal:  Pathogens       Date:  2022-02-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.